亚太地区数字治疗市场预测至 2028 年 - COVID-19 影响和应用区域分析 [糖尿病、心血管疾病、中枢神经系统 (CNS) 疾病、呼吸系统疾病、戒烟、肌肉骨骼疾病等] 和分销渠道（患者、提供者、付款者和雇主）
No. of Pages: 117 | Report Code: TIPRE00028818 | Category: Technology, Media and Telecommunications
No. of Pages: 117 | Report Code: TIPRE00028818 | Category: Technology, Media and Telecommunications
市场的增长归因于人口的不断增长未确诊的慢性病，如心血管疾病和糖尿病，以及数字治疗初创企业数量的增加。然而，与数据安全相关的网络威胁和风险限制了市场的增长。
数字疗法有助于监测和管理各种慢性疾病，例如糖尿病、心脏病和呼吸道感染。政府采取了各种举措来支持数字治疗市场的增长。 2021 年，印度政府发起了国家数字健康使命 (NDHM)，以提高电子医疗保健模式的偏好和采用。它改善了医疗保健行业的健康状况。邀请大量私人玩家参与演出。例如，Tattvan 是印度第一家远程医疗公司，其“brick & 医疗服务”拥有广泛的远程医疗业务。砂浆”为二线、三线城市、四线城镇的患者提供医疗诊断、及时治疗、指导和最佳咨询的模式。
政府资助报销和接受监测的患者数量的增加预计将鼓励初创公司进入数字治疗行业。由于症状较少，该地区很大一部分人不知道自己患有糖尿病。同样，根据第 10 版 IDF 糖尿病地图集发布的数据，20-79 岁年龄段的约 2.397 亿糖尿病患者估计不知道自己患有这种疾病。尽早诊断糖尿病至关重要，因为它会导致视力丧失、肾衰竭和严重情况下死亡等疾病。此外，未确诊的糖尿病患者比未患糖尿病的患者更频繁地选择医疗服务；因此，他们的医疗保健支出高于健康人。未确诊糖尿病病例的增加归因于低收入和高收入国家筛查设施不足。由于全球近一半人口不知道糖尿病，因此迫切需要对糖尿病患者进行筛查、诊断和提供适当的护理。数字疗法通过让个人自行监测自己的健康状况，帮助及早发现糖尿病的体征和症状。因此，未确诊糖尿病人口的增加可能会推动未来几年数字治疗市场的增长。
Strategic insights for Asia Pacific Digital Therapeutics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 767.23 Million |
| Market Size by 2028 | US$ 3,470.31 Million |
| Global CAGR (2021 - 2028) | 24.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 应用
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Digital Therapeutics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Digital Therapeutics Market is valued at US$ 767.23 Million in 2021, it is projected to reach US$ 3,470.31 Million by 2028.
As per our report Asia Pacific Digital Therapeutics Market, the market size is valued at US$ 767.23 Million in 2021, projecting it to reach US$ 3,470.31 Million by 2028. This translates to a CAGR of approximately 24.1% during the forecast period.
The Asia Pacific Digital Therapeutics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Digital Therapeutics Market report:
The Asia Pacific Digital Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Digital Therapeutics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Digital Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Digital Therapeutics Market
